(Q38782227)

6 September 2017

title

MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling (English)

1 reference

6 September 2017

1 reference

1 reference

Jian-Zhang Li

1

1 reference

6 September 2017

Zhen-Long Wang

2

1 reference

6 September 2017

Wan-Hai Xu

3

1 reference

6 September 2017

Qing Li

4

1 reference

6 September 2017

Lin Gao

5

1 reference

6 September 2017

Zi-Ming Wang

6

1 reference

6 September 2017

publication date

31 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

34

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

181-188

1 reference

Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

The microRNA pathway and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Imaging survival and function of transplanted cardiac resident stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNA-495 mimics delivery inhibits lung tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

MicroRNA-495 induces breast cancer cell migration by targeting JAM-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2016.1156690

10.3109/07357907.2016.1156690

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference